pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Enbrel
drug
save

etanercept

Marketedupdated 3mo ago
by $AMGN AMGEN INC
Approved
annual revenue · 2024–2024peak $3.8B
2024: $3.8B2024$3.8B
community read0 votes

🐶 often sniffed alongside

top 3
  • tagApproval384 co-mentions · 98 sources
  • drugETICOVO8 co-mentions · 4 sources
  • companySamsung Bioepis Co Ltd4 co-mentions · 4 sources

indications

investigational
Rheumatoid Arthritis

all catalysts(0)

nothing on the calendar yet

Trials studying etanercept

  • phase3A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasisactive not recruitingn=135
  • phase3A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participantsactive not recruitingn=120
  • phase3Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Studycompletedn=34
  • phase1Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCterminatedn=212
  • phase1A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorderscompletedn=141
  • phase3A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritisrecruitingn=458
  • phase1A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participantscompletedn=48
  • phase3A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDscompletedn=509
more trials →

News(3)

  • Court halts Colorado price cap on Amgen's blockbuster Enbrel
    US District Court Judge Daniel Domenico in Colorado granted Amgen's preliminary injunction to stop a 70% price cap on its blockbuster autoimmune drug Enbrel, arguing that the cap could cause "econo…
    endpoints · 1mo ago
  • STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
    U.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug Enbrel
    stat · 1mo ago
  • STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug
    A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen
    stat · 1mo ago
brand
Enbrel
generic
etanercept
indication
Plaque Psoriasis (Psoriasis Vulgaris)
phase
marketed
approved
1998-11-02
Data sources
openFDA · ClinicalTrials.gov
last refreshed 22m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?